130 related articles for article (PubMed ID: 16475247)
1. Swedish roadtrip.
Herrera S
Nat Biotechnol; 2006 Jan; 24(1):15. PubMed ID: 16475247
[No Abstract] [Full Text] [Related]
2. Earlier stage biotechs attract partners.
Ratner M
Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
[No Abstract] [Full Text] [Related]
3. Michigan's next wave of biopharmaceutical entrepreneurship.
Kerppola R; van de Walle M; Surine S
Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575
[No Abstract] [Full Text] [Related]
4. Selling out.
Martin JF
Nat Biotechnol; 2010 Apr; 28(4):315-7. PubMed ID: 20383912
[No Abstract] [Full Text] [Related]
5. Exiting this year and into the next.
Nat Biotechnol; 2005 Dec; 23(12):1451. PubMed ID: 16333272
[No Abstract] [Full Text] [Related]
6. Never again.
Scott C
Nat Biotechnol; 2010 Feb; 28(2):131. PubMed ID: 20139946
[No Abstract] [Full Text] [Related]
7. A very firm handshake: biotech's growing negotiating power.
Thiel KA
Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
[No Abstract] [Full Text] [Related]
8. Benefits of biotech clusters questioned.
Sheridan C
Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
[No Abstract] [Full Text] [Related]
9. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
10. Antiinfective biotechs face partnering gap.
Sheridan C
Nat Biotechnol; 2005 Feb; 23(2):155-6. PubMed ID: 15696131
[No Abstract] [Full Text] [Related]
11. Anthony Coyle.
Coyle A
Nat Biotechnol; 2011 Mar; 29(3):187. PubMed ID: 21390006
[No Abstract] [Full Text] [Related]
12. Elias Zerhouni.
Zerhouni E
Nat Biotechnol; 2011 Mar; 29(3):188. PubMed ID: 21390007
[No Abstract] [Full Text] [Related]
13. The promise of the East: India and China as R&D options.
Goodall S; Janssens B; Wagner K; Wong J; Woods W; Yeh M
Nat Biotechnol; 2006 Sep; 24(9):1061-4. PubMed ID: 17061321
[No Abstract] [Full Text] [Related]
14. Does biotech M&A benefit investors?
Jacobs T
Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
[No Abstract] [Full Text] [Related]
15. Genentech makes its first-ever acquisition.
Hollmer M
Nat Biotechnol; 2007 Jan; 25(1):4-5. PubMed ID: 17211375
[No Abstract] [Full Text] [Related]
16. Biotech parks proliferate, despite concerns over sustainability.
Jia H; Jayaraman KS; Orellana C
Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
[No Abstract] [Full Text] [Related]
17. [Role of academic medicine for innovations in development of drugs and biomedicine technology].
Manns MP
Dtsch Med Wochenschr; 2013 Oct; 138(40):1993-4. PubMed ID: 24065403
[No Abstract] [Full Text] [Related]
18. Filters for preparing to meet a venture capitalist.
Christoffersen R
Nat Biotechnol; 2003 Jul; 21 Suppl():BE49-50. PubMed ID: 12874981
[No Abstract] [Full Text] [Related]
19. Convincing a venture capitalist to invest in your idea.
Dooley JF; Dooley JF
Nat Biotechnol; 2003 Jul; 21 Suppl():BE45-8. PubMed ID: 12874980
[No Abstract] [Full Text] [Related]
20. Paths to entrepreneurship in the life sciences.
Mehta S
Nat Biotechnol; 2004 Dec; 22(12):1609-12. PubMed ID: 15605429
[No Abstract] [Full Text] [Related]
[Next] [New Search]